There are two sides to every patient’s lung cancer.

“Ask not just what the cancer is doing to you. Ask what you are doing to the cancer.”

– DR. KENNETH PIENTA, MEDICAL ONCOLOGIST AT JHU
MUKHERJEE S. “CANCER’S INVASION EQUATION.” THE NEW YORKER, SEPTEMBER 2017.

GENOMIC

Actionable Tumor Mutations

PROTEOMIC

Patient’s Immune Response to Cancer

Source: Image adapted from Chen and Mellman 2016 for educational purposes.

Understand both sides with Biodesix Lung Reflex®

Integrated blood-based genomic and proteomic results reveal both sides of lung cancer in 72-hours, expediting time to treatment.

  • cfDNA and cfRNA with ddPCR™
  • Actionable mutations: EGFR, ALK, ROS1, RET, BRAF, and KRAS​
  • Reduces treatment delays and expedites clinical trial enrollment
LEARN MORE  
THE GENES IN THE GENESTRAT TEST AND THE VERISTRAT PROTEOMIC TEST ARE COVERED BY MEDICARE AND MANY PRIVATE PAYERS.

  • Identifies a chronic inflammatory disease state associated with aggressive cancer​
  • Predictive capability: results are predictive of outcomes, independent of ECOG performance status, mutation status, and treatment choice​
LEARN MORE  

We are committed to supporting your treatment strategies and improving the lives of patient’s with lung cancer.

SAVE TIME. 72-HOUR TURNAROUND.

SAVE TISSUE. ONE SIMPLE BLOOD DRAW.

TWO SIDES OF CANCER. GENOMIC & PROTEOMIC TESTING.

$0 OUT OF POCKET EXPENSE FOR MEDICARE AND MEDICAID PATIENTS.

Interested in ordering a test kit?

REQUEST KIT   VIEW VIDEO  

 

Get in touch

Contact us